This study was supported by the National Key R&D Program of China(No.2016YFC1000405 and No.2018YFC1002903)
Objective:To investigate whether peroxisome proliferator-activated receptorγ(PPARγ)agonists,rosiglitazone and GW1929,activate the phosphatidylinositol 3-kinase(PI3K)-AKT/protein kinase B pathway and the mitogen-acti...